In the present study, we tested the hypothesis elevated leptin promotes disease pathogenesis, and that antagonism of leptin would improve B and T lymphocyte hyperreactivity and lower blood pressure in the NZBWF1 mouse model of SLE. Here, LEP is linked to systemic lupus erythematosus.